Where they are now
What becomes of buzzy biotech startups after VC checks are deposited and the cheerful press releases fade from memory?
For one company, there were layoffs announced in an early-morning email, STAT’s Kate Sheridan reports. Another startup has cold brew on tap but no CEO, while a third is taking a Lego-inspired approach to developing new drugs.
That’s all in Something Ventured, our quarterly series that keeps tabs on whether yesterday’s well-funded startups are keeping all those vibrant promises.
Read more.
.png)
No hay comentarios:
Publicar un comentario